210 related articles for article (PubMed ID: 18823260)
1. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
Lööf T; Elfman P; Ström P; Törngren A; Borgström L
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
[TBL] [Abstract][Full Text] [Related]
2. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
3. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
4. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
5. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler.
Borgström L; Asking L; Thorsson L
Int J Clin Pract; 2005 Dec; 59(12):1488-95. PubMed ID: 16351685
[TBL] [Abstract][Full Text] [Related]
6. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
7. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
[TBL] [Abstract][Full Text] [Related]
8. Can patients use all dry powder inhalers equally well?
Gustafsson P; Taylor A; Zanen P; Chrystyn H
Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
[TBL] [Abstract][Full Text] [Related]
9. Do all dry powder inhalers show the same pharmaceutical performance?
Taylor A; Gustafsson P
Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
[TBL] [Abstract][Full Text] [Related]
10. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
Bisgaard H; Klug B; Sumby BS; Burnell PK
Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964
[TBL] [Abstract][Full Text] [Related]
11. Are outcomes the same with all dry powder inhalers?
Thomas M; Williams AE
Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002
[TBL] [Abstract][Full Text] [Related]
12. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
Franks M; Briggs P
Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
Pharmazie; 2004 Sep; 59(9):692-9. PubMed ID: 15497751
[TBL] [Abstract][Full Text] [Related]
14. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
Tarsin W; Assi KH; Chrystyn H
J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers.
Bhalla RK; Watson G; Taylor W; Jones AS; Roland NJ
J Asthma; 2008 Nov; 45(9):814-9. PubMed ID: 18972301
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169
[TBL] [Abstract][Full Text] [Related]
17. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
[TBL] [Abstract][Full Text] [Related]
18. Dry powder inhalers: which factors determine the frequency of handling errors?
Wieshammer S; Dreyhaupt J
Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
[TBL] [Abstract][Full Text] [Related]
19. The Genuair® inhaler: a novel, multidose dry powder inhaler.
Chrystyn H; Niederlaender C
Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]